Diabetes and cancer
Vigneri, Paolo, Frasca, Francesco, Sciacca, Laura, Pandini, Giuseppe, Vigneri, Riccardo·2009·Endocrine Related Cancer
Cited by (1,000)
Items 101–200 of 1,000
- Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and PrognosisShuwen Dong, Zheng Wang, Kunwei Shen, Xiaosong Chen · 2021 · Frontiers in Oncology
- Obesity and Bone Health: A Complex RelationshipAna Piñar-Gutiérrez, Cristina García‐Fontana, Beatriz García-Fontana, Manuel Muñoz‐Torres · 2022 · International Journal of Molecular Sciences
- Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled TrialsHu, Weiting, Song, Rui, Cheng, Rui, Liu, Caihong, Guo, Rui, Tang, Wei, Zhang, Jie, Zhao, Qian, Li, Xing, Liu, Jing · 2022 · Frontiers in Endocrinology
- Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational StudiesØystein Karlstad, Jakob Starup‐Linde, Peter Vestergaard, Vidar Hjellvik, Marloes T. Bazelier, Marjanka K. Schmidt, Morten Andersen, Anssi P. Auvinen, Jari K. Haukka, Kari Furu et al. · 2013 · Current Drug Safety
- Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayAndréia Vasconcelos-dos-Santos, Hector F.B.R. Loponte, Natália Rodrigues Mantuano, Isadora de Araújo Oliveira, Iron F. De Paula, Leonardo K. Teixeira, Julio Cesar Madureira de‐Freitas‐Junior, Katia Calp Gondim, Norton Heise, Ronaldo Mohana‐Borges et al. · 2017 · Oncogenesis
- The association of micronucleus frequency with obesity, diabetes and cardiovascular diseaseMaria Grazia Andreassi, Roberto Barale, Patricia Iozzo, Eugenio Picano · 2010 · Mutagenesis
- Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participantsJenkins, David J A, Willett, Walter C, Yusuf, Salim, Hu, Frank B, Glenn, Andrea J, Liu, Simin, Mente, Andrew, Miller, Victoria, Bangdiwala, Shrikant I, Gerstein, Hertzel C et al. · 2024 · The Lancet Diabetes & Endocrinology
- GLP‐1 based therapies: differential effects on fasting and postprandial glucoseMark S. Fineman, Brenda B. Cirincione, David G. Maggs, Michaëla Diamant · 2012 · Diabetes Obesity and Metabolism
- Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-upGianluca Perseghin, Giliola Calori, Guido Lattuada, Francesca Ragogna, Erika Dugnani, Maria Paola Garancini, Paolo Crosignani, Marco Villa, Emanuele Bosi, Giacomo Ruotolo et al. · 2012 · Acta Diabetologica
- Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications.N. Stefan, H. Häring, F. Hu, M. Schulze · 2016 · The Lancet Diabetes and Endocrinology
- A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over timeHulda Hrund Björnsdóttir, Araz Rawshani, Aidin Rawshani, Stefan Franzén, Ann‐Marie Svensson, Naveed A. Sattar, Soffia Guðbjörnsdóttir · 2020 · Scientific Reports
- Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic PatientsMatteo Monami, Claudia Colombi, Daniela Balzi, Ilaria Dicembrini, Stefano Giannini, Cecilia Melani, Valentina Vitale, Desiderio Romano, Alessandro Barchielli, Niccolò Marchionni et al. · 2010 · Diabetes Care
- Diabetes mellitus and risk of prostate cancer in the EuropeanProspectiveInvestigation into Cancer and NutritionKonstantinos K. Tsilidis, Naomi E. Allen, Paul N. Appleby, Sabine Rohrmann, Ute Nöthlings, Larraitz Arriola, Marc James Gunter, Véronique Chajès, Sabina Rinaldi, Isabelle Romieu et al. · 2014 · International Journal of Cancer
- Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up studyRikje Ruiter, Loes E. Visser, Myrthe P. P. van Herk‐Sukel, J.W.W. Coebergh, Harm Reinout Haak, Petronella H.L.M. Geelhoed-Duijvestijn, Sabine M. J. M. Straus, Ron M. C. Herings, Bruno H. Ch. Stricker · 2011 · Diabetologia
- Insulin and its analogues and their affinities for the IGF1 receptorAimee J. Varewijck, J. A. M. J. L. Janssen · 2012 · Endocrine Related Cancer
- Insulin Resistance: The Increased Risk of CancersLeszek Szablewski · 2024 · Current Oncology
- From tumor cell metabolism to tumor immune escapeMartín Villalba, Moeez Ghani Rathore, Nuria López-Royuela, Ewelina Krzywińska, Johan Garaude, Nerea Allende-Vega · 2012 · The International Journal of Biochemistry & Cell Biology
- Plasma-free amino acid profiles are predictors of cancer and diabetes developmentXinyan Bi, Christiani Jeyakumar Henry · 2017 · Nutrition and Diabetes
- Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohortsYanan Ma, Wanshui Yang, Mingyang Song, Stephanie A. Smith‐Warner, Juhong Yang, Yanping Li, Wenjie Ma, Yang Hu, Shuji Ogino, Frank B. Hu et al. · 2018 · British Journal of Cancer
- Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patientsLaura Sciacca, Riccardo Vigneri, Andrea Tumminia, Francesco Frasca, Sebastiano Squatrito, Lucia Frittitta, Paolo Giovanni Vigneri · 2013 · Nutrition Metabolism and Cardiovascular Diseases
- Associations Between General and Abdominal Adiposity and Mortality in Individuals With Diabetes MellitusDiewertje Sluik, Heiner Boeing, Jukka Montonen, Tobias Pischon, Rudolf Kaaks, Brigit Teucher, Anne Marie Tjønneland, Jytte Halkjær, Tina Landsvig Berentzen, Kim Overvad et al. · 2011 · American Journal of Epidemiology
- A general mechanism for conditional expression of exaggerated sexually‐selected traitsIan A. Warren, Hiroki Gotoh, Ian M. Dworkin, Douglas J. Emlen, Laura Corley Lavine · 2013 · BioEssays
- Association between markers of glucose metabolism and risk of colorectal cancerJinming Xu, Ye Yao, Han Wu, Penelope J. Duerksen-Hughes, Honghe Zhang, Peiwei Li, Jian Huang, Jun Jie Yang, Yihua Wu, Dajing Xia · 2016 · BMJ Open
- Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysisShahid Mahmood, Robert J. MacInnis, Dallas R. English, Amalia Karahalios, Brigid Mary Lynch · 2017 · International Journal of Epidemiology
- Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping ReviewElsa Vitale, Alessandro Rizzo, Kazuki Santa, Emilio Jirillo · 2024 · Biology
- Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insightsNtsoaki Annah Nyane, Thabiso Bethwel Tlaila, Tanki Gabriel Malefane, Duduzile Edith Ndwandwe, Peter Mark Oroma Owira · 2017 · European Journal of Pharmacology
- Proinsulin Binds with High Affinity the Insulin Receptor Isoform A and Predominantly Activates the Mitogenic PathwayRoberta Malaguarnera, Antonella Sacco, Concetta Voci, Giuseppe Pandini, Riccardo Vigneri, Antonino Belfiore · 2012 · Endocrinology
- Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studiesMukete Franklin Sona, Seung‐Kwon Myung, Keeho Park, Jargalsaikhan Galsuren · 2018 · Japanese Journal of Clinical Oncology
- Cross-talk between Insulin and Wnt Signaling in PreadipocytesPalsgaard, Jane, Emanuelli, Brice, Winnay, Jonathon N., Sumara, Grzegorz, Karsenty, Gerard, Kahn, C. Ronald · 2012 · Journal of Biological Chemistry
- Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon CancerYves Lecarpentier, VICTOR A. CLAES, Alexandre Vallée, Jean‐Louis Hébert · 2017 · PPAR Research
- Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetesKasper Broedbaek, Allan Weimann, Elisabeth Specht Stovgaard, Henrik Enghusen Poulsen · 2011 · Free Radical Biology and Medicine
- The Insulin Receptor: A New Target for Cancer TherapyRoberta Malaguarnera, Antonino Belfiore · 2011 · Frontiers in Endocrinology
- The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patientsMei‐Yueh Lee, Kun‐Der Lin, Pi‐Jung Hsiao, Shyi‐Jang Shin · 2011 · Metabolism
- Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US populationAmikar Sehdev, Ya‐Chen Tina Shih, Benjamin G. Vekhter, Marc B. Bissonnette, Olufunmilayo Ibironke Olopade, Blasé N. Polite · 2014 · Cancer
- Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 DiabetesHarold E. Lebovitz · 2011 · Diabetes Care
- Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladderByung Hyo Cha · 2011 · World Journal of Gastroenterology
- The impact of diabetes on survival in women with ovarian cancerArvind Bakhru, Ronald J. Buckanovich, Jennifer J. Griggs · 2011 · Gynecologic Oncology
- The Antidiabetic Activity ofNigella sativaand Propolis on Streptozotocin‐Induced Diabetes and Diabetic Nephropathy in Male RatsHaddad A. El Rabey, Madeha N. Al‐Seeni, Amal S. Bakhashwain · 2017 · Evidence-based Complementary and Alternative Medicine
- Selenium Supranutrition: Are the Potential Benefits of Chemoprevention Outweighed by the Promotion of Diabetes and Insulin Resistance?Caroline R.B. Rocourt, Wen‐Hsing Cheng · 2013 · Nutrients
- Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activationYuanying Gong, Yufang Ma, Maksim Sinyuk, Sudan N. Loganathan, Reid C. Thompson, Jann Nagina Sarkaria, Wenbiao Chen, Justin Durla Lathia, Bret C. Mobley, Stephen W. Clark et al. · 2015 · Neuro-Oncology
- Diabetes Mellitus Increases the Risk of Bladder Cancer: An Updated Meta-Analysis of Observational StudiesHong Fang, Baodong Yao, Yujie Yan, Huilin Xu, Yinan Liu, Hongmei Tang, Jie Zhou, Lili Cao, Weijie Wang, Jinling Zhang et al. · 2013 · Diabetes Technology & Therapeutics
- Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differencesHeike U. Krämer, Ben Schöttker, Elke Raum, Hermann Brenner · 2011 · European Journal of Cancer
- Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohortDorothee M. Baur, Jens Klotsche, Ole‐Petter R. Hamnvik, Caroline Sievers, Lars Pieper, Hans‐Ulrich Wïttchen, Günter Karl Stalla, Roland Michael Schmid, Stefanos N. Kales, Christos Socrates Mantzoros · 2010 · Metabolism
- Type 2 Diabetes and Cancer: What Is the Connection?Dara Cannata, Yvonne Fierz, Archana Vijayakumar, Derek LeRoith · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
- Potential Efficacy of Broccoli Sprouts as a Unique Supplement for Management of Type 2 Diabetes and Its ComplicationsZahra Bahadoran, Parvin Mirmiran, Fereidoun Azizi · 2013 · Journal of Medicinal Food
- Diabetes Mellitus and Cancer Risk in a Network of Case-Control StudiesCristina Bosetti, Valentina Rosato, Jerry Polesel, Fabio Levi, Renato Talamini, Maurizio Montella, Eva Negri, Alessandra Tavani, Antonella Zucchetto, Silvia Franceschi et al. · 2012 · Nutrition and Cancer
- High glucose enhances progression of cholangiocarcinoma cells via STAT3 activationCharupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, Sopit Wongkham · 2016 · Scientific Reports
- Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics scienceKentaro Inamura, Tsuyoshi Hamada, Susan Bullman, Tomotaka Ugai, Shinichi Yachida, Shuji Ogino · 2022 · Gut
- Quantitative Analysis of Pancreatic Polypeptide Cell Distribution in the Human PancreasXiaojun Wang, Mark C. Zielinski, Ryosuke Misawa, Patrick Wen, Tian-Yuan Wang, Chengzhang Wang, Piotr Witkowski, Manami Hara · 2013 · PLoS ONE
- Diabetes and cancer II: role of diabetes medications and influence of shared risk factorsAdedayo A. Onitilo, Jessica Marie Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A.R. Doi · 2012 · Cancer Causes & Control
- Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patientsSimona Bo, Giovannino Ciccone, Rosalba Rosato, Paola Villois, Giovanni Appendino, Ezio Ghigo, Giorgio Grassi · 2011 · Diabetes Obesity and Metabolism
- Latest insights into the risk of cancer in diabetesHiroshi Noto, Atsushi Goto, Tetsuro Tsujimoto, Keiichiro Osame, Mitsuhiko Noda · 2013 · Journal of Diabetes Investigation
- Pioglitazone and the Risk of Bladder Cancer: A Meta-AnalysisElena Pavlova Filipova, Katya Hristova Uzunova, Krassimir Kalinov, Toni Yonkov Vekov · 2017 · Diabetes Therapy
- Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugsAhmed Olatunde, Manisha Nigam, RAHUL KUNWAR SINGH, Abhaya Shikhar Panwar, Abdulwahab Lasisi, Fahad Abdulrahman Alhumaydhi, Vijay Kumar, Abhay Prakash Mishra, Javad Sharifi‐Rad · 2021 · Cancer Cell International
- Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studiesIsabelle N Colmers-Gray, Samantha L. Bowker, Lisa Tjosvold, Jeffrey A. Johnson · 2012 · Diabetes & Metabolism
- Type 2 Diabetes and Breast Cancer: The Interplay Between Impaired Glucose Metabolism and Oxidant StressFerroni, Patrizia, Riondino, Silvia, Buonomo, Oreste, Palmirotta, Raffaele, Guadagni, Fiorella, Roselli, Mario · 2015 · Oxidative Medicine and Cellular Longevity
- A New Approach for Diagnosis of Diabetes and Prediction of Cancer Using ANFISC. Kalaiselvi, G. M. Nasira · 2014 · World Congress on Computing and Communication Technologies (WCCCT)
- Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patientsSui‐Foon Lo, Shih‐Ni Chang, Chih‐Hsin Muo, Shih‐Yin Chen, Fang‐Yin Liao, Shu‐Wei Dee, Pei‐Chun Chen, Fung‐Chang Sung · 2012 · International Journal of Cancer
- PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF AxisVeronica Vella, Maria Luisa Nicolosi, Stefania Giuliano, Maria Bellomo, Antonino Belfiore, Roberta Malaguarnera · 2017 · Frontiers in Endocrinology
- Report of the J apan Diabetes Society/ J apanese Cancer Association joint committee on diabetes and cancerMasato Kasuga, Kohjiro Ueki, Naoko Tajima, Mitsuhiko Noda, Ken Ohashi, Hiroshi Noto, Atsushi Goto, Wataru Ogawa, Ryuichi Sakai, Shoichiro Tsugane et al. · 2013 · Cancer Science
- A Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer PatientsYusook Jeong, Hye Sook Han, Hyo Duk Lee, Jiyoul Yang, Jiwon Jeong, Moon Ki Choi, Jihyun Kwon, Hyun‐Jung Jeon, Taekeun Oh, Ki Hyeong Lee et al. · 2016 · Cancer Research and Treatment
- Dietary components and risk of cardiovascular disease and all-cause mortality: a review of evidence from meta-analysesChun Shing Kwok, Martha Gulati, Erin D. Michos, Jessica E. Potts, Pensée Wu, Lorraine Watson, Yoon Kong Loke, Christian David Mallen, Mamas A. Mamas · 2019 · European Journal of Preventive Cardiology
- Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemiaZ. Racil, Filip Rázga, J. Drápalová, Lucie Burešová, Daniela Žáčková, Martina Palacková, Lukáš Semerád, Ludmila Malášková, Martin Haluzı́k, Jiřı́ Mayer · 2013 · Haematologica
- Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studiesZhi‐Feng Miao, Hao Xu, Ying-Ying Xu, Zhen-ning Wang, Tingting Zhao, Yongxi Song, Huimian Xu · 2017 · Oncotarget
- Diabetes and risk of bladder cancerTodd A. MacKenzie, Michael S. Zens, Assiamira M. Ferrara, Alan R. Schned, Margaret Rita Karagas · 2010 · Cancer
- Metformin: The hidden chronicles of a magic drugKhalid Mahmood, Muhammad Naeem, Nasir Ali Rahimnajjad · 2012 · European Journal of Internal Medicine
- Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to LifestyleAhmad H. AlKhatib, Catherine Tsang, Jaakko O. Tuomilehto · 2018 · International Journal of Molecular Sciences
- Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activatorsDaniel Bedinger, Sean H. Adams · 2015 · Molecular and Cellular Endocrinology
- Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in ChinaPian-hong Zhang, Zhongwen Chen, Duo Lv, Yuyang Xu, Weiling Gu, Xuhui Zhang, Yuan-luo Le, Honghong Zhu, Yimin Zhu · 2012 · BMC Public Health
- Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseasesGanji Purnachandra Nagaraju, Syed Farhan Zafar, Bassel F. El‐Rayes · 2013 · Nutrition Reviews
- Cancer risk in patients with type 2 diabetes mellitus and their relativesXiangdong Liu, Kari Hemminki, Asta Försti, Kristina Sundquist, Jan Sundquist, Jianguang Ji · 2015 · International Journal of Cancer
- Diabetes mellitus and the risk of bladder cancerYongping Xu, Rui Huo, Xi Chen, Xuefeng Yu · 2017 · Medicine
- IntroductionRobyn L. Houlden · 2018 · Canadian Journal of Diabetes
- Metformin: prevention of genomic instability and cancer: a reviewNajafi, Masoud, Cheki, Mohsen, Rezapoor, Saeed, Geraily, Ghazale, Motevaseli, Elahe, Carnovale, Carla, Clementi, Emilio, Shirazi, Alireza · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
- Metformin and Breast Cancer: Molecular TargetsJoão Faria, Gonçalo de Câmara Negalha, Ana Azevedo, Fátima Martel · 2019 · Journal of Mammary Gland Biology and Neoplasia
- Role of Metformin in Suppressing 1,2-Dimethylhydrazine-Induced Colon Cancer in Diabetic and Non-Diabetic Mice: Effect on Tumor Angiogenesis and Cell ProliferationDalia K. Zaafar, Sawsan A. Zaitone, Yasser M. Moustafa · 2014 · PLoS ONE · Retracted
- The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studiesYongbo Wang, P. Yan, Tao Fu, Jingping Yuan, G. Yang, Yanfei Liu, Z.-J. Zhang · 2020 · Diabetes & Metabolism
- Cancer Biology and Prevention in DiabetesSwayam Prakash Srivastava, Julie E. Goodwin · 2020 · Cells
- Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort StudiesZhaowei Zhu, Xiaohua Zhang, Zhoujun Shen, Shan Zhong, Xianjin Wang, Yingli Lu, Xu Chen · 2013 · PLoS ONE
- Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer RiskSho‐ichi Yamagishi, Takanori Matsui, Kei Fukami · 2014 · Rejuvenation Research
- Hyperinsulinemia Drives Epithelial Tumorigenesis by Abrogating Cell CompetitionYuya Sanaki, Rina Nagata, Daisuke Kizawa, Pierre Léopold, Tatsushi Igaki · 2020 · Developmental Cell
- Targeting the insulin-like growth factor pathway in hepatocellular carcinomaMónica Enguita‐Germán · 2014 · World Journal of Hepatology
- Macrophages and T cells in metabolic disorder-associated cancersDaniel Taranto, D. Kloosterman, L. Akkari · 2024 · Nature Reviews. Cancer
- Effects of Sulfonylureas on Tumor Growth: A Review of the LiteratureGiulia Pasello, Loredana Urso, PierFranco Conte, Adolfo Gino Favaretto · 2013 · The Oncologist
- High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive diseasePamela Minicozzi, Franco Berrino, Federica Sebastiani, Fabio Falcini, Rosa Vattiato, Francesca Cioccoloni, Gioia Calagreti, Mario Fusco, Maria Francesca Vitale, Rosario Tumino et al. · 2013 · European Journal of Cancer
- Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetesMarco Gallo, Giovanna Muscogiuri, Francesco Felicetti, Antongiulio Faggiano, Francesco Trimarchi, Emanuela Arvat, Riccardo Vigneri, Annamaria Colao · 2017 · Metabolism
- The Global Burden of DiabetesJessica L. Harding, Mary Beth Weber, Jonathan E. Shaw · 2024 · Wiley eBooks
- The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological ConditionsVirmani, Ashraf, Pinto, Luigi, Bauermann, Otto, Zerelli, Saf, Diedenhofen, Andreas, Binienda, Zbigniew K., Ali, Syed F., van der Leij, Feike R. · 2015 · Molecular Neurobiology
- Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysisLonneke Veronique van de Poll-Franse, Harm Reinout Haak, J.W.W. Coebergh, Maryska L.G. Janssen-Heijnen, V.E.P.P. Lemmens · 2012 · Diabetologia
- The Association between Diabetes Mellitus and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-AnalysisTing Chen, Delu Song, Guangliang Shan, Ke Wang, Yiwei Wang, Jin Ma, Yong Zhong · 2013 · PLoS ONE
- Type 2 diabetes mellitus—current therapies and the emergence of surgical optionsHarold E. Lebovitz · 2011 · Nature Reviews Endocrinology
- Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathwayHongpeng Jiang, Qianqian Yao, Yongbo An, Linlin Fan, Jing Wang, Huiying Li · 2021 · Phytomedicine
- In vitro and in vivo antitumoral action of metformin on hepatocellular carcinomaZhan Qu, Yangde Zhang, Mingmei Liao, Yuxiang Chen, Jinfeng Zhao, Yifeng Pan · 2012 · Hepatology Research
- The Association Between Self-Reported Diabetes and Cancer Incidence in the NIH-AARP Diet and Health StudyGabriel Y. Lai, Yikyung Park, Patricia A. Hartge, Albert R. Hollenbeck, Neal D. Freedman · 2013 · The Journal of Clinical Endocrinology & Metabolism
- Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 DiabetesXilin Yang, Wing Yee So, Ronald C.W., Alice P.S. Kong, Heung Man Lee, Linda W.L. Yu, Chun‐Chung Chow, Risa Ozaki, Gary T C Ko, Juliana C.N. Chan · 2010 · Diabetes Care
- Incidence of Diabetes in Colorectal Cancer SurvivorsSimron Singh, Craig C. Earle, Sandy J. Bae, Hadas D. Fischer, Lingsong Yun, Peter C. Austin, Paula A. Rochon, George Anderson, Lorraine Lucille Lipscombe · 2016 · JNCI Journal of the National Cancer Institute
- High glucose levels promote the proliferation of breast cancer cells through GTPasesYilin Hou, Man Zhou, Jing Xie, Ping Chao, Qiyu Feng, Jun Wu · 2017 · Breast Cancer Targets and Therapy
- Mechanisms Involved in Childhood Obesity-Related Bone FragilityM. Faienza, G. D'Amato, M. Chiarito, G. Colaianni, S. Colucci, M. Grano, F. Corbo, G. Brunetti · 2019 · Frontiers in Endocrinology
- Temporal trends in population‐based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 yearsYuhree Kim, Aslam M. Ejaz, Amit Tayal, Gaya Spolverato, John F. P. Bridges, Robert A. Anders, Timothy Michael Pawlik · 2014 · Cancer
- Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidenceBrandon L. Pierce · 2012 · Urologic Oncology Seminars and Original Investigations